Home » Topics » Regulatory

Regulatory
RSS

FDA approves Zoloft for premenstrual dysphoric disorder

May 22, 2002

E.U. approval for Avonex for early use in high-risk MS patients

May 21, 2002

Actonel 35 mg approved for once-weekly dosing in postmenopausal osteoporosis

May 21, 2002

Paxil approved in Canada for posttraumatic stress disorder

May 17, 2002

Tacrolimus for psoriasis scheduled for marketing within three to four years

May 10, 2002

Positive pharmacokinetic results for buccal desmopressin

May 10, 2002

IND submitted for nitroglycerin lingual spray

May 10, 2002

Avalox i.v. cleared for market introduction in Germany

May 8, 2002

Protonix delayed-release tablets approved for long-term treatment of Zollinger-Ellison syndrome

May 7, 2002

Generex completes proof-of-concept study for buccal fentanyl citrate

May 6, 2002

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...